OSRH
OSRH
NASDAQ · Biotechnology

Osr Holdings Inc

$0.55
+0.04 (+6.94%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.84M 7.68M 7.81M
Net Income -2,005,672 -1,738,578 -1,581,297
EPS
Profit Margin -25.6% -22.6% -20.2%
Rev Growth +12.8% +0.1% +6.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.67M 1.99M 1.69M
Total Equity 9.75M 9.93M 10.19M
D/E Ratio 0.17 0.20 0.17
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,263,216 -2,551,790 -2,649,024
Free Cash Flow -1,406,564 -1,071,377 -1,645,390